Skip to main content
Research in Pharmaceutical Sciences logoLink to Research in Pharmaceutical Sciences
. 2014 May-Jun;9(3):193–198.

Effect of Lagerstroemia tomentosa and Diospyros virginiana methanolic extracts on different drug-resistant strains of Mycobacterium tuberculosis

B Nasr Esfahani 1, F Hozoorbakhsh 2, Kh Rashed 3, SA Havaei 1, K Heidari 4, Sh Moghim 1,*
PMCID: PMC4311284  PMID: 25657789

Abstract

Mycobacterium tuberculosis (MTB) is the causative agent of tuberculosis. The increasing incidence of multi drug resistance tuberculosis (MDR-TB) and extensively drug resistance tuberculosis (XDR-TB) worldwide highlighted the urgent need to search for alternative antimycobacterial agents. More and more people in developing countries utilize traditional medicine for their major primary health care needs. It has been determined that pharmaceutical plant, Lagerstroemia tomentosa and Diospyros virginiana, possesses some antibacterial effect. In this study, the antimycobacterial effects of L. tomentosa and D. virginiana methanolic extracts on sensitive and resistant isolates of MTB were examined. Leaf methanolic extract was prepared using methanol 70%. Sensitivity and resistance of isolates was determined by proportion method. The effects of two different methonolic extract concentrations (20 and 40 μg/ml) of the plants were examined against 6 sensitive and resistant strains of MTB with different patterns of drug resistance. MTB H37Rv (ATCC 27294) was set as control in all culturing and sensitivity testing processes. The results showed that L. tomentosa and D. virginiana methanolic extracts had weak inhibitory effect on different strains of MTB. The highest percentage of inhibition for L. tomentosa and D. virginiana was observed 38% and 33.3%, respectively.

Keywords: Lagerstroemia tomentosa, Diospyros virginiana, Methanolic extract, Antimycobacterial effect

INTRODUCTION

Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis (TB), is one of the most top killers in the world. In 2011, 8.7 million people afflicted with TB, including 1.1 million cases among people with HIV. It was estimated that 1.4 million people died from TB this year (1). In addition, today, the emergence of resistance to antimycobacterial agents has become an important public health issue in many developing countries.

The increasing incidence of multi drug resistance tuberculosis (MDR-TB) and extensively drug resistance TB (XDR-TB) worldwide highlights the urgent need to search for newer anti-tuberculosis compounds (2). More and more people in developing countries utilize traditional medicine for their major primary health care needs (3). Medicinal plants offer a great hope to fulfill these needs and have been used for curing diseases for many centuries (4). The scientific experiments which have been carried out on antimicrobial properties of plant components were first documented in the late 19th century (5). Plants have been a source of effective chemo-therapeutic agents for various infectious diseases and there is a growing interest in the development of drugs of plant origin. A number of plants have been shown significant in vitro antimycobacterial activities (6). These findings have, therefore, stimulated further research towards the isolation of new antimycobacterial agents from natural products (6). Lagerstroemia commonly known as Crape myrtle or Crepe myrtle, is a genus of around 50 species of deciduous and evergreen trees and shrubs native to the Indian subcontinent, southeast Asia, northern Australia and parts of Oceania, cultivated in warmer climates around the world. It is a member of the Lythraceae, which is also known as the Loosestrife family (7,8). The extract of Lagerstroemia speciosa has shown antinociceptive, antidiarrhoel and cytotoxic activities and is effective on Arthrinium sacchari, Chaetomium funicola, Gram positive and Gram negative bacteria (9,10,11). L. parviflora Roxb leaf extract has antipyretic and antitussive activity and is effective against bacterial species such as Shigella dysenteriae, E.coli, Streptococcus pneumoniae, and Bacillus cereus (12,13).

Diospyros virginiana continue to serve as viable source of drugs for the world population and several plant-based drugs are in extensive clinical use (14).

Till now antimycobacterial effect of these two plant species have not been determined. In this study the antimycobacterial activity of L. tomentosa and D. virginiana methanolic extracts on different drug resistant phenotype strains of MTB were evaluated.

MATERIALS AND METHODS

Plant material

Plant leaves from L. tomentosa were obtained from Al-Zohiriya garden, Giza, Egypt in May 2011 and authenticated by Department of Botany, National Research Center (NRC) and Consultant of Plant Taxonomy at the Ministry of Agriculture of Orman botanical garden, Giza, Egypt. Leaves from D. virginiana were obtained from the Agricultural Research Center, Giza, Egypt in May 2011 and authenticated by Department of Botany, and NRC.

Preparation of the extract

Five hundred grams of air dried powdered from the leaves of L. tomentosa or D. virginiana was prepared and extracted separately with 6 liters of methanol 70% at room temperature 3 times until exhaustion by maceration. The extracts were concentrated under reduced pressure to give 54 and 58 g of crude extract respectively.

Phytochemical analysis

The plant extract was tested for the presence of bioactive compounds according to the following standard tests: Molisch's test for carbohydrates, Shinoda test for flavonoids, Forth test for saponins, Farnsworth test for coumarins, Salkowski's test for terpenes and sterols, FeCl3 and Mayer's reagents for detecting of tannins and alkaloids, respectively (15,16,17).

Mycobacterium strains

A total isolates of MTB species were collected from Tuberculosis Centers of Isfahan. Isolates were subcultured on Löwenstein-Jensen (LJ) media and incubated for 21 days at 37 °C and characterized by conventional methods including staining, colony characteristics, pigmentation, growth temperature and time of growth.

Sensitivity evaluation of Mycobacterium tuberculosis

Drug susceptibility testing was performed using the proportion method with isoniazid (0.2 μg ml−1), rifampin (40 μg ml−1), streptomycin (4 μg ml−1) and ethambutol (2 μg ml−1) (18,19). Briefly, the subcultures prepared in Lowenstein-Jensen media and incubated for 21 days. A standard suspension of 107 colony forming unit (CFU)/ml (equivalent to # 1 McFarland standard) of MTB isolates was prepared by dispersing of 3 to 5 colonies of Mycobacteria in distilled water. Subsequently, LJ medium without and with subjected antibiotics were prepared and inoculated with 0.2 ml of 10-2 and 10-4 dilutions of a McFarland 1.0 standard of each strains of MTB. The inoculated plates were then incubated for 42 days at 37 °C (first reading 28 days, second reading 42 days) and the percentage inhibition of CFU was determined (20). Resistance was defined as growth on drug containing tubes greater than 1% of the growth of drug free control medium for isoniazid, rifampin, ethambutol and 10% for streptomycin (21,22). MTB H37Rv (ATCC 27294) was set as control in all culturing and sensitivity testing processes.

Determination of antimycobacterial activity

Antimycobacterial effects of L. tomentosa and D. virginiana on the resistant and sensitive isolates of MTB with two concentrations of the methanolic extract (20 μg/ml and 40 μg/ml) were determined according to the standard procedures (19).

Löwenstein-Jensen medium without and with subjected plants, were prepared and inoculated with 0.2 ml of 10-2 and 10-4 dilutions of a McFarland 1.0 standard of each isolate of MTB. Rifampin and isoniazid were used as the positive controls whereas water was used as negative control. MTB H37Rv (ATCC 27294) was used in sensitivity testing processes. The percentage of inhibition was determined after 3 to 6 weeks of inoculation by the following formula (23,24):

graphic file with name RPS-9-193-g001.jpg

RESULTS

The results showed that the leaf methanol extract of L. tomentosa contained different compounds as triterpenes, carbohydrates, flavonoids, alkaloids, tannins and coumarins (Table 1). The leaf methanol extract of D. virginiana composed of compounds such as carbohydrates, flavonoids, tannins and triterpenes. Both plants were free of saponin (Table 1).

Table 1.

Phytochemical analysis of D. virginiana and L. tomentosa methanol leaf extract.

graphic file with name RPS-9-193-g002.jpg

Several isolates of MTB species were identified by conventional biochemical and phenotyping methods. Drug susceptibility testing was performed using proportion method with isoniazid (0.2 μg ml−1), rifampin, (40 μg ml−1), streptomycin (4 μg ml−1) and ethambutol (2 μg ml−1) and 6 strains with different patterns of drug resistance were selected for the study. MTB H37Rv (ATCC 27294) was used as control in all processes. In Table 2, the resistance patterns of all MTB isolates are shown.

Table 2.

Drug sensitivity of Mycobacterium tuberculosis isolates to rifampin, isoniazid, streptomycin and ethambutol.

graphic file with name RPS-9-193-g003.jpg

Antimycobacterial effect of 20 and 40 μg/ml methanolic extract against different drug resistant phenotype isolates of MTB were determined using proportion method. The results showed that L. tomentosa and D. virginiana extract had weak inhibitory effect against MTB strains. The inhibitory percentages of the extracts are shown in Table 3.

Table 3.

Effect of different concentration of L. tomentosa and D. virginiana methanol leaf extracts on drug sensitive and resistant M. tuberculosis.

graphic file with name RPS-9-193-g004.jpg

DISCUSSION

The prevalence of MDR strains of MTB is an important reason for the resurgence of TB as a major disease in many parts of the world. There is, therefore, an urgent need for new, inexpensive TB drugs which are effective and with fewer side effects. In many countries, medicinal plants are used by traditional medical practitioners to combat TB. Medicinal plants offer a great hope to fulfill these needs and have been used for curing diseases for many centuries.

Chopra and coworkers reported that the bark of the L. tomentosa is considered stimulant and febrifuge, leaves and flowers are used as purgative (29). Kirtikar and Basu suggested that the roots are astringent (30). No previous biological and phytochemical examinations of L. tomentosa leaves have been undertaken.

In this study, the antimycobacterial activity of the L. tomentosa and D. virginiana methanolic extracts (20 and 40 μg/ml) on drug sensitive and resistant MTB strains was determined by proportion method according to standard procedures (18,31). The methanolic extracts of 2 plants showed a weak inhibitory activity against MTB strains (Table 3). This activity for L. tomentosa was ranged from very low (8.3 %) to moderate (38 %) on resistance strains of M. tuberculosis. Meanwhile, this activity for D. virginiana was observed from very low (3.2 %) to moderate (33.3 %) on strains of M. tuberculosis. These plants had similar activity on rifampin-isoniazid resistant strain of MTB (16.6 % for 20 μg/ml concentration and 25% for 40 μg/ml concentration). Percentage of inhibition for L. tomentosa and D. virginiana on H37Rv ATCC 27294 was 22% at 40 μg/ml and 20 % at 20 μg/ml. The leaf extract of L. tomentosa was more effective at 40 μg/ml (P≤0.08) whereas D. virginiana was more effective at 20 μg/ml concentration (P≤0.09) (Table 3). Biological and phytochemical examinations of D. virginiana have not been undertaken but activities of other Diospyros species have been evaluated. Clement and Oluremi suggested that Diospyros bateri and Diospyros monbuttensis have shown strong antibacterial activity against a wide range of gram-positive and gram-negative bacteria (32,33).

Sunity Singh and coworkers have shown that the chloroform extract of root and bark of Diospyros kaki had remarkably good antifungal activity against all fungi (34). Renu Gupta and colleagues evaluated anti-tuberculosis activity of Allium cepa by proportion method. Allium cepa showed 35% inhibition. L. tomentosa compared with Allium cepa has stronger anti-tuberculosis activity (20). However, further studies on isolation and identification of the effective fractions of these two plants against MTB are warranted.

CONCLUSION

The results of this study showed that the antimycobacterial effect of L. tomentosa plant extract on rifampin, isoniazid and streptomycin resistance strains of MTB is 35.4% for 20 μg/ml and 38% for 40 μg/ml concentration. The results of the study of D. virginiana and L. tomentosa antimycobacterial effect showed that different concentrations of their methanolic extract (20 and 40 μg/ml) had a weak inhibitory effect on sensitive and resistant phenotype of MTB. Further studies on isolation and identification of the effective fractions of these two plants against MTB are warranted.

ACKNOWLEDGMENTS

This assay was supported by grant 175769 from Islamic Azad University, Science and Research Branch.

REFERENCES

  • 1.WHO library cataloguing-in-publication data global tuberculosis control: WHO report. 2011. www.who.int .
  • 2.Esmi Serkani J, Nasr Isfahani B, Safaei HGh, Kasra Kermanshahi R, Asghari Gh. Evaluation of the effect of Humulus lupulus alcoholic extract on rifampin-sensitive and resistant isolates of MTB. ResPharm Sci. 2012;7:235–242. [PMC free article] [PubMed] [Google Scholar]
  • 3.Houghton PJ. The role of plants in traditinal medicine and current therapy. J Altern Complement Med. 1995;1:131–143. doi: 10.1089/acm.1995.1.131. [DOI] [PubMed] [Google Scholar]
  • 4.Heinrich M, Gibbons S. Ethnopharmacology in drug 3. Discovery: an analysis of its role and potential contribution. J Pharm Pharmacol. 2001;53:425–32. doi: 10.1211/0022357011775712. [DOI] [PubMed] [Google Scholar]
  • 5.Zaika LL. Spices and herbs: their antimicrobial activity and its determination. J Food Safety. 1975;9:97–118. [Google Scholar]
  • 6.Newton SM, Lau C, Gurcha SS, Besra GS, Wright CW. The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria Canadensis. J Ethnopharmacol. 2002;79:57–67. doi: 10.1016/s0378-8741(01)00350-6. [DOI] [PubMed] [Google Scholar]
  • 7.“Lagerstroemia”. Australian Plant Name Index (APNI), IBIS database. Centre for Plant Biodiversity Research, Australian Government. http://www.anbg.gov.au/cgi-bin/apni?taxon_id=36201 .
  • 8.Graham SA, Crisci JV, Hoch PC. Cladistic analysis of the Lythraceae sensulato based on morphological characters. Botanical Journal of the Linnean Society. 1993;113:1–33. [Google Scholar]
  • 9.Atiqur Rahman Md, Uddin N, Hasanuzzaman Md, Rahman AA. Antinociceptive, antidiarrhoeal and cytotoxic activities of Lagerstroemia speciosa (L.) pers. Pharmacologyonline. 2011;1:604–612. [Google Scholar]
  • 10.Ambujakshi HR, Surendra V, Haribabu T, Goli D. Antibacterial activity of leaves of Lagerstroemia speciosa (L) pers. Journal of Pharmacy Research. 2009;2:1028. [Google Scholar]
  • 11.Sato J, Goto K, Nanjo F, Kawai Sh, Murata K. Antifungal activity of plant extracts against Arthrinium sacchari and Chaetomium funicola. J Biosci Bioeng. 2000;90:442–446. [PubMed] [Google Scholar]
  • 12.Mazumder A, Singn SK, Mazumder R, Basu SP, Saha BP. Antimicrobial action of the leaf extract of Lagerstroemia parviflora Roxb. Ancient Science of Life. 2002;90:442–446. [PMC free article] [PubMed] [Google Scholar]
  • 13.Mazumder A, Saha BP, Basu SP, Mazumder R, Boominathan R, Parimala Devi B, et al. Evaluation of antitussive activity of Lagerstroemia parviflora leaf extract. Phytother Res. 2004;18:780–782. doi: 10.1002/ptr.1571. [DOI] [PubMed] [Google Scholar]
  • 14.Phillips Jan. Jefferson City, Missouri: Missouri Department of Conservation; 1979. Wild edibles of missouri; p. 40. [Google Scholar]
  • 15.Sofowra A. Ibadan, Nigeria: Spectrum Books Ltd; 1993. Medicinal plants and traditional medicine in Africa; pp. 191–289. [Google Scholar]
  • 16.Harborne JB. London: Chapman and Hall. Ltd; 1973. Phytochemical methods; pp. 49–188. [Google Scholar]
  • 17.Trease GE, Evans WC. 11th edn. Chapter 5. London: Bailliere Tindall; 1989. Pharmacology. [Google Scholar]
  • 18.Charley W, Mitchell M, Kidd K. In the antimycobacterial susceptibility tests. New York: Williams & Wilkins Press; 1999. Antibiotics laboratory medicine. [Google Scholar]
  • 19.Williams DL, Spring L, Collins L, Miller LP, Heifets LB, Gangadharam PRJ, et al. Contribution of rpoB mutations to development of rifamycin cross-resistance in MTB. Antimicrob Agents Chemother. 1998;42:1853–1857. doi: 10.1128/aac.42.7.1853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gupta R, Thakur B, Singh P, Singh HB, Sharma VD, Katoch VM. Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant MTB isolates. Indian J Med Res. 2010;131:809–813. [PubMed] [Google Scholar]
  • 21.CQF L, Alrz B, Anno IS, Telles MAS. Standartization of broth microdilution method for MTB. Mem Inst Oswaldo Cruz. 2000;95:127–129. doi: 10.1590/s0074-02762000000100021. [DOI] [PubMed] [Google Scholar]
  • 22.NCCLS-National Committee for Clinical Laboratory Standards. Villanova; Tentative standard M24-T, NCCLS; 2002. Antimycobacterial susceptibility testing for MTB. [Google Scholar]
  • 23.Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen JO, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993;328:521–526. doi: 10.1056/NEJM199302253280801. [DOI] [PubMed] [Google Scholar]
  • 24.Nasr Isfahani B, Tavakoli A, Salehi M, Tazhibi M. Detection of rifampin resistance patterns in MTB strains isolated in Iran by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing methods. Mem Inst Oswaldo Cruz. 2006;101:597–602. doi: 10.1590/s0074-02762006000600004. [DOI] [PubMed] [Google Scholar]
  • 25.Navarro-García VM, Luna-Herrera J, Rojas Bribiesca G, Álvarez-Fitz P, Yolanda Ríos M. Antibacterial activity of aristolochia brevipes against multidrug-resistant MTB. Molecules. 2011;16:7357–7364. doi: 10.3390/molecules16097357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mohammed Buzayan M, Rajab El-Garbulli F. Antibacterial activity of medicinal aqueous plant extracts against MTB. Malaysian Journal of Microbiology. 2012;8:203–206. [Google Scholar]
  • 27.Cantrell CL, Franzblau SG, Fischer NH. Antimycobacterial plants terpenoids. Planta Med. 2001;67:685–694. doi: 10.1055/s-2001-18365. [DOI] [PubMed] [Google Scholar]
  • 28.Mann A, Amupitan JO, Oyewale AO, Okogun JI, Ibrahim K. An Ethnobotanical survey of indigenous flora for treating tuberculosis and other respiratory diseases in Niger State. J Phytomed & Therap. 2007;12:1–12. [Google Scholar]
  • 29.Chopra RN, Nayar SL, Chopra IC. New Delhi: In Glossary & Indian Medicinal Plants, CSIR; 1958. pp. 546–554. [Google Scholar]
  • 30.Kirtikar KR, Basu BD. Dehradun, India: International Book Distributors and Publishers; 1935. Indian Medicinal Plant; p. 72. [Google Scholar]
  • 31.Nasr Isfahani B, Bahadorane bagh baderani M, Esmi Zh, Hoseini N, Tavakoli dastjerdi A, Javadi A, et al. Iran: Isfahan university publisher; 2009. Tuberculosis; p. 164. [Google Scholar]
  • 32.Anie C, Arhewoh M, Henry Okeri A. Antimicrobial activity of crude extracts of diospyros monbuttensis (fam: ebenaceae) root and stem barks. International Journal of Biomedical Research. 2011;1:18–24. [Google Scholar]
  • 33.Oluremi BB, Osungunna MO, Ogbole OO. Phytochemical and antimicrobial screening of the leaf extract of Diospyros barteri Gurke. Pharmacognosy Journal. 2010;2:405–408. [Google Scholar]
  • 34.Singh S, Prasad R, Pathania K, Joshi H. Antifungal activity of Plumbagin & isodiospyrin from Diospyros kaki root bark. Pelagia Research Library Asian Journal. 2012;2:1–5. [Google Scholar]

Articles from Research in Pharmaceutical Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES